blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1884515

EP1884515 - Substituted indanyl sulfonamide compounds, their preparation and use as medicaments [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.01.2009
Database last updated on 02.07.2024
Most recent event   Tooltip30.01.2009Application deemed to be withdrawnpublished on 04.03.2009  [2009/10]
Applicant(s)For all designated states
Laboratorios del Dr. Esteve S.A.
Av. Mare de Déu de Montserrat, 221
08041 Barcelona / ES
[2008/06]
Inventor(s)01 / Alcalde-Pais, Maria de La Ermitas
Fac. de Farm. Univ. de Barcelona Avda. Joan XXIII
08028 Barcelona / ES
02 / Frigola-Constansa, Jordi
Cami de Can Candelier 9-B, 3er ,1a
08960 Sant Just Desvern / ES
03 / Holenz, Joerg
Plöjarvärgen 19
SE 15023 Enhörna / SE
04 / Merce-Vidal, Ramon
Avda. Mare de Deu de Montserrat, 221
08041 Barcelona / ES
05 / Mesquida-Estevez, Maria de les Neus
Fac. de Farm. Univ. de Barcelona Avda. Joan XXIII
08028 Barcelona / ES
06 / Lopez-Perez, Sara
Fac. de Farm. Univ. de Barcelona Avda. Joan XXIII
08028 Barcelona / ES
 [2008/06]
Representative(s)Carpintero Lopez, Francisco, et al
Herrero & Asociados, S.L.
Agustín de Foxá, 4-10
28036 Madrid / ES
[N/P]
Former [2008/06]Carpintero Lopez, Francisco, et al
Herrero & Asociados, S.L. Alcalá 35
28014 Madrid / ES
Application number, filing date06380220.131.07.2006
[2008/06]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1884515
Date:06.02.2008
Language:EN
[2008/06]
Search report(s)(Supplementary) European search report - dispatched on:EP18.12.2006
ClassificationIPC:C07D295/12, C07D333/62, C07D513/04, A61K31/429, A61K31/496
[2008/06]
CPC:
C07D295/135 (EP,US); A61P1/00 (EP); A61P1/06 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P43/00 (EP); C07D333/62 (EP,US); C07D513/04 (EP,US) (-)
Designated contracting states[2008/42]
Former [2008/06]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Substituierte Indanylsulfonamid-Verbindungen, ihre Herstellung und Verwendung als Medikament[2008/06]
English:Substituted indanyl sulfonamide compounds, their preparation and use as medicaments[2008/06]
French:Composés indanylsulfamides, leur préparation et utilisation comme médicament[2008/06]
Examination procedure07.08.2008Application deemed to be withdrawn, date of legal effect  [2009/10]
12.09.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2009/10]
Fees paidPenalty fee
Additional fee for renewal fee
31.07.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4129656  (LANG HANS-JOCHEN, et al) [X] 20,21 * examples 1-4 *;
 [A]EP0088282  (SCHERING AG [DE]) [A] 1-19,22-27 * Formula I;; page 1, lines 14-30 *;
 [A]EP0456133  (CIBA GEIGY AG [CH]) [A] 1-19,22-27 * Formula I;; page 3, lines 30-51 *;
 [A]EP0747374  (SQUIBB BRISTOL MYERS CO [US]) [A] 1-19,22-27 * Formula I;; page 14, lines 11-46 *;
 [X]  - CLEMENS RUFER, FRANK BAHLMANN, EBERHARD SCHRÖDER, IRMGARD BÖTTCHER, "Nichtsteroidale Entzündungshemmer 8. Entzündungshemmende Methansulfonanilide III", EUR. J. MED. CHEM. CHIM. THER., (1982), vol. 17, no. 2, pages 173 - 180, XP009075830 [X] 20,21 * Schemes 1, 4;;; tables 2-5,8 *
 [X]  - CHUN-SING LI, W. CAMERON BLACK, CHI-CHUNG CHAN, ANTHONY FORD-HUTCHINSON, JACQUES-YVES GAUTHIER, ROBERT GORDON, DANIEL GUAY ET AL., "Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives", J. MED. CHEM., (1995), vol. 38, pages 4897 - 4905, XP002410328 [X] 20,21 * tables 1-5 *

DOI:   http://dx.doi.org/10.1021/jm00025a007
 [X]  - NATHALIE QUIMET, CHI-CHUNG CHAN, STELLA CARLESON, DAVID CLAVEAU, ROBERT GORDON, DANIEL GUAY, CHUN-SING LI, MARC OUELLET, ET AL., "Substituted heterocyclic analogs as selective COX-2 inhibitors in the Flosulide class", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (1999), vol. 9, pages 151 - 156, XP002410329 [X] 20,21 * tables 1-3 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(98)00705-7
 [X]  - CHANG HA PARK, XAVIER SIOMBOING, SAID YOUS, BERNARD GRESSIER, MICHEL LUYCKX, PHILIPPE CHAVATTE, "Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, (2002), vol. 37, pages 461 - 468, XP002410330 [X] 20,21 * figures 1-4 *

DOI:   http://dx.doi.org/10.1016/S0223-5234(02)01373-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.